Phase I/II clinical trial of WT1 peptide vaccine for the children with malignancies
Not Applicable
- Conditions
- pediatric acute leukemia or pediatric malignant solid tumors
- Registration Number
- JPRN-UMIN000002990
- Lead Sponsor
- Osaka Medical Center and Research Institute for Maternal and Child Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
<main exclusion criteria> MDS and/or MPN before allogeneic HSCT. Inappropriate condition. Others.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method